Dergiler / The Journal of Pediatric Research / 2021 / Cilt: 8 - Sayı: 1

Successful Orthotopic Heart Transplantation in Patients with Becker Muscular Dystrophy

Sayfa
98–101
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

One of the patients remains under follow-up with a left ventricular assist device as a bridge-to-transplantation, while the other underwent successful orthotopic heart transplantation.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Cardiomyopathy is a major factor contributing to mortality and morbidity in patients with Duchenne and Becker muscular dystrophies (DMD/ BMD), and is therefore among the increasingly important findings.
📊
Temel Bulgular & Veri:This defect brings about changes in the cardiac muscle in three phases: an initial hypertrophic stage, followed by an arrhythmogenic stage, and finally end-stage dilated cardiomyopathy due to increased loss of myocytes.
💡
Sonuç & Katkı:One of the patients remains under follow-up with a left ventricular assist device as a bridge-to-transplantation, while the other underwent successful orthotopic heart transplantation.
🔬Tür:Araştırma Makalesi
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Alan Parametreleri

Özet

Cardiomyopathy is a major factor contributing to mortality and morbidity in patients with Duchenne and Becker muscular dystrophies (DMD/ BMD), and is therefore among the increasingly important findings. These X-linked recessive disorders involve the deficiency or absence of dystrophin in the skeletal muscle as well as the myocardium. This defect brings about changes in the cardiac muscle in three phases: an initial hypertrophic stage, followed by an arrhythmogenic stage, and finally end-stage dilated cardiomyopathy due to increased loss of myocytes. While cardiac involvement can be observed in carriers of BMD and DMD, the incidence of dilated cardiomyopathy is reported to be higher in BMD patients than DMD patients. The only curative treatment option for medically refractory dystrophinopathic end-stage heart failure is heart transplantation. In this report, we present two patients, 14 and 15 years of age, who presented with dilated cardiomyopathy and were diagnosed with muscular dystrophy. One of the patients remains under follow-up with a left ventricular assist device as a bridge-to-transplantation, while the other underwent successful orthotopic heart transplantation.

🔖

Bu Makaleye Atıf Yap

AYDIN, D., DOĞAN, E., ÜLGER, Z., LEVENT, E. (2021). Successful Orthotopic Heart Transplantation in Patients with Becker Muscular Dystrophy. The Journal of Pediatric Research, Cilt: 8 - Sayı: 1, 98–101. https://ajindex.com/articles/403231

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (8)

  1. Papa AA, D’Ambrosio P, Petillo R, Palladino A, Politano L. Heart transplantation in patients with dystrophinopathic cardiomyopathy: Review of the literature and personal series Intractable Rare Dis Res 2017; 6:95-101
  2. Emery AE. Population frequencies of inherited neuromuscular diseases. A world survey. Neuromuscul Disord 1991; 1:19-29
  3. Cripe L, Kinnett K, Uzark K, Eghtesady P, Wong B, Spicer R. P1.14 Cardiac transplantation in Duchenne muscular dystrophy: a case report. Neuromuscul Disord 2011; 21:645
  4. Rees W, Schüler S, Hummel M, Hetzer R. Heart transplantation in patients with muscular dystrophy associated with end-stage cardiomyopathy. J Heart Lung Transplant 1993; 12:804-7
  5. David M. Sleeper LA, Colan SD, et al. Characteristics and outcomes of cardiomyopathy in children with duchenne or becker muscular dystrophy: a comparative study from the pediatric cardiomyopathy registry Am Heart J 2008; 155:998- 1005
  6. Wu RS, Gupta S, Brown RN, et al. Clinical outcomes after cardiac transplantation in muscular dystrophy patients. J Heart Lung Transplant 2010; 29:432-8
  7. Ruiz-Cano MJ, Delgado JF, Jiménez C, et al. Successful heart transplantation in patients with inherited myopathies associated with endstage cardiomyopathy. Transplant Proc 2003; 35:15131515
  8. Amodeo A, Adorisio R. Left ventricular assist device in Duchenne cardiomyopathy: Can we change the natural history of cardiac disease? Int J Cardiol 2012; 29:161:e43.